Skip to main content

Search form

You are here

Urology

Urology Funded Projects

Grants

10th International Symposium on Urolithiasis
A Diet-Endocrine Study Of Breast And Prostate Cancer
A Phase 2 Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of DCR-PHXC Solution for Injection (subcutaneous use) in Patients with Primary Hyperoxaluria
A Phase 3 Double-Blind, Randomized, Placebo-Controlled, Multi-Center Study to Evaluate the Efficacy, Safety and Tolerability of Vibegron in Men with Overactive Bladder (OAB) Symptoms on l Therapy for Benign Prostatic Hyperplasia (BPH)
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of MitoGel on Ablation of Upper Urinary Tract Urothelial Carcinoma
A Phase 3 Study to Evaluate the Safety and Efficacy of Tc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men with Biopsy Proven Low-Grade Prostate Cancer who are Candidates for Active Surveillance(proSPECT-AS)
A PHASE Ib/II, OPEN-LABEL STUDY OF THE SAFETY AND PHARMACOLOGY OF ATEZOLIZUMAB ADMINISTERED WITH OR WITHOUT BACILLE CALMETTE-GUÉRIN IN PATIENTS WITH HIGH-RISK NON¿MUSCLEINVASIVE BLADDER CANCER
A Phase II study of Sporadic Angiomyolipomas (AMLs) Growth Kinetics while on Everolimus Therapy
A Phase III, Open Label Study to Evaluate the Safety and Efficacy of INSTILADRIN® (rAd-IFN/Syn3) Administered Intravesically to Patients with High Grade, BCG Unresponsive Non-Muscle Invasive Bladder C
A Prospective Observational Cohort Study of Patients with Castration Resistant Prostate Cancer
A Prospective, Phase 3, Multi-Center, Single-Arm, Imaging Study Investigating the Safety and Diagnostic Performance of rhPSMA-7.3 (18F) PET Ligand in Men with Newly Diagnosed Prostate Cancer
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Apalutamide in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer Who are Candidates for Radical Prostatectomy
A Survivorship Action Partnership (ASAP) USA
Allena 0000713-01
Allergan 120 - BOTOX in the Treatment of Urinary Incontinence Due to Neurognic Detrusor Overactivity in Patients 5 to 17 Years of Age
Allergan 121 - Long-term Extension Study of BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 8 to 17 Years of Age
An Extension Study of MRI/US Fusion Imaging and Biopsy in Combination with Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue
An Open-label, Baseline-controlled, Multicenter, Phase 3 Dose-titration Study to Evaluate Efficacy, Safety and Pharmacokinetics of Mirabegron in Children and Adolescents from 3 to less than 18 Years of Age
Artificial Urinary Sphincter Clinical Outcomes
AUAER Education Workshop

Pages